EUVIMEDEUVIMED entdecken
Crossref

Presentation, Management, and Outcomes of Patients With Giant Pheochromocytoma

Bahar Bahrani Fard iD, Nasrin Nikravangolsefid iD, Justin W Maroun, Ashton Cross, Trenton Foster, Travis J McKenzie, Benzon Dy, Melanie Lyden, William F Young iD, Irina Bancos iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Bahar Bahrani Fard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Adrenalectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Data on giant pheochromocytomas (PHEOs), defined based on size 10 cm or greater, are scarce.

Objective

This work aimed to compare presentation, management, and outcomes of patients with giant vs non–giant PHEOs.

Methods

A retrospective cohort study was conducted in a referral center from 2000 to 2023. Consecutive patients with giant PHEOs and randomly chosen patients with non–giant PHEO (referents) were studied at a 1:6 ratio. Outcomes included perioperative complications, metastases, and mortality.

Results

Of 828 patients with PHEOs, 31 (3.7%) had giant PHEO (median size 12 cm, interquartile range [IQR] 10.0-13.5 cm). In comparison to referents (n = 186, median size 4 cm, IQR, 2.9-5.0 cm), patients with giant PHEO had more symptoms of catecholamine excess (median of 2 vs 1; P = .04) and presented with a higher prevalence of severe catecholamine excess (76% vs 30%; P < .0001). Adrenalectomy was performed in 94% of patients with giant PHEOs and 100% of referents. In addition to preoperative α-adrenergic blockade (89%), metyrosine was used in 14 (7%) patients, mostly in patients with giant PHEOs (26% vs 3%; P < .0001). Patients with giant PHEOs had a higher perioperative complication rate (31% vs 10%; P = .004). During a median follow-up of 3 years, metastases developed at a higher rate in patients with giant PHEOs (45% vs 4% in referents; P < .0001). Disease-specific mortality was 7% in patients with giant PHEOs and 0% in referents (P = .02).

Conclusion

Patients with giant PHEOs compared to referents were more symptomatic, had a higher degree of catecholamine excess, and had a higher rate of perioperative complications. Almost half of patients with giant PHEOs developed metastases, warranting close follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaAdrenal Gland NeoplasmsAdrenalectomyHumansMaleFemaleRetrospective StudiesMiddle AgedAdultAgedTreatment OutcomeFollow-Up StudiesPostoperative ComplicationsTumor BurdenPrognosis

Stichwörter der Autor:innen

adrenal massadrenalectomydiagnosismetastasesoutcomessize

Autor:innen und Institutionen

  • Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
  • Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

ORCID-Profile: Bahar Bahrani Fard, Nasrin Nikravangolsefid, William F Young, Irina Bancos

Zitieren

APA

Bahrani Fard, B., Nikravangolsefid, N., Maroun, J. W., Cross, A., Foster, T., McKenzie, T. J., Dy, B., Lyden, M., Young, W. F., & Bancos, I. (2025). Presentation, Management, and Outcomes of Patients With Giant Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae612

Vancouver

Bahrani Fard B, Nikravangolsefid N, Maroun JW, Cross A, Foster T, McKenzie TJ, et al. Presentation, Management, and Outcomes of Patients With Giant Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae612

BibTeX
@article{BahraniFard2025,
  author = {Bahrani Fard, Bahar and Nikravangolsefid, Nasrin and Maroun, Justin W and Cross, Ashton and Foster, Trenton and McKenzie, Travis J and Dy, Benzon and Lyden, Melanie and Young, William F and Bancos, Irina},
  title = {Presentation, Management, and Outcomes of Patients With Giant Pheochromocytoma},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae612}
}
Kostenlos starten →